Section Arrow
ALMR.NASDAQ
- Alamar Biosciences Inc
Quotes are at least 15-min delayed:2026/06/21 04:24 EDT
Regular Hours
Last
 21.96
+1.76 (+8.71%)
Day High 
22.24 
Prev. Close
20.2 
1-M High
22.76 
Volume 
996.57K 
Bid
20.71
Ask
22.9
Day Low
20.2 
Open
20.45 
1-M Low
18.845 
Market Cap 
1.40B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 20.8 
20-SMA 20.55 
50-SMA -- 
52-W High 27.2 
52-W Low 18.845 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.65/--
Enterprise Value
1.44B
Balance Sheet
Book Value Per Share
-2.57
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
74.21M
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
BFLYButterfly Network8.9+3.19+55.87%-- 
ABTAbbott Laboratories88.41-0.09-0.10%24.76PE
TNONTenon Medical Inc0.35-0.2521-41.87%-- 
BSXBoston Scientific Corp45.29+0.34+0.76%18.95PE
MDTMedtronic plc79.34+1.2+1.54%22.16PE
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Alamar Biosciences Inc is a proteomics company engaged in protein detection and analysis. The company has developed its own NULISA (NUcleic Acid Linked Immuno-Sandwich Assay) technology as the foundation of its Precision Proteomics platform enabling the detection and quantification of protein biomarkers in a single sample with ultra-high sensitivity and high specificity, even from very small volumes of biofluid. The company operates in single segment and focuses on developing a good sensitive proteomic liquid biopsy platform and sells instruments, consumables, and services based on this platform to enable early detection of diseases. The products of the company includes NULISAseq Panels, NULISAqpcr Assays, and others.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.